Close
CDMO Safety Testing 2026
Novotech
Drug Research

Theraclone doses first patient in Phase 1 TCN-032 drug trial

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Drug Research

Smart Thermal Packaging Enhancing Drug Stability Systems

Maintaining the stability of sensitive pharmaceutical compounds requires more than just standard insulation. Smart thermal packaging integrates advanced temperature control and real-time tracking to create a secure distribution environment. By ensuring that drugs remain within strict thermal parameters throughout their journey, these systems protect the efficacy of medications and enhance the reliability of pharmaceutical distribution networks worldwide.
Drug Research

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...
Drug Research

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.
- Advertisement -

Theraclone Sciences has dosed first patient in a randomized, double-blind, dose-escalation Phase 1 trial investigating TCN-032 as a treatment for influenza A virus.

TCN-032 was discovered utilizing Theraclone’s I-STAR platform.The trial aims to investigate the safety profile of a single intravenous administration of TCN-032 compared to placebo.The study expects to recruit aorund 40 volunteers at a single US site and will also provide pharmacokinetic and immunogenicity data.

Theraclone executive chairman and acting CEO Steven Gillis said I-STAR has repeatedly demonstrated an ability to identify natural human antibodies with exceptionally biologic activity and therapeutic potential.

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
Download the Media Pack to activate your presence across the global pharma and life sciences ecosystem.

Latest stories

Previous article
FDA approves Amphastar Enoxaparin Sodium Injection
Next article
The Medicines Company introduces new Cleviprex formulation

Related stories

Drug Research

Smart Thermal Packaging Enhancing Drug Stability Systems

Maintaining the stability of sensitive pharmaceutical compounds requires more than just standard insulation. Smart thermal packaging integrates advanced temperature control and real-time tracking to create a secure distribution environment. By ensuring that drugs remain within strict thermal parameters throughout their journey, these systems protect the efficacy of medications and enhance the reliability of pharmaceutical distribution networks worldwide.
Drug Research

Fujifilm Advances Drug Discovery with New Cyclic Peptide Screening Platform

FUJIFILM Corporation has developed a new screening methodology aimed...
Drug Research

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.
Drug Research

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
Smart Thermal Packaging

Smart Thermal Packaging Enhancing Drug Stability Systems

Real Time Visibility Pharma Transport

Real Time Visibility Enhancing Pharma Transport Efficiency